This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Intervet Inc., Intervet International B.v.. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boxmeer, NL (2013)
- Groeningen, NL (2014 - 2020)
Company Filing History:


Years Active: 2013-2020
Title: Martinus Antonius Johannes Thijssen: Innovator in Vaccine Development
Introduction
Martinus Antonius Johannes Thijssen is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of vaccine development, holding a total of 4 patents. His work focuses on improving the efficacy and testing of vaccines, particularly in the context of porcine health.
Latest Patents
Thijssen's latest patents include a "Ready to use porcine vaccine," which relates to methods for determining the antigen content of a first antigen in a mixture containing multiple antigens. This invention also introduces a potency test for antigens in combination vaccines, allowing for accurate determination of antigen content even in the presence of antibodies that bind to the antigen. Another significant patent is the "Potency test for vaccine formulations," which shares similar methodologies for antigen content determination and potency testing in vaccine mixtures.
Career Highlights
Throughout his career, Thijssen has worked with prominent companies in the veterinary pharmaceutical industry, including Intervet Inc. and Intervet International B.V. His expertise in vaccine development has positioned him as a key figure in advancing veterinary medicine.
Collaborations
Thijssen has collaborated with notable professionals in his field, including Mark Garrett and Urs Peter Bruderer. These collaborations have further enhanced his research and development efforts in vaccine technology.
Conclusion
Martinus Antonius Johannes Thijssen's contributions to vaccine development are significant and impactful. His innovative patents and collaborations reflect his dedication to improving animal health through advanced vaccine solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile